Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
2011
Analysis of CD16 + CD56 dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
48
Citations
NaN
KQI